1 Remicade (infliximab) Drug Market Overview
1.1 Product Overview and Scope of Remicade (infliximab) Drug
1.2 Remicade (infliximab) Drug Segment by Type
1.2.1 Global Remicade (infliximab) Drug Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Brands Drugs
1.2.3 Generic Drugs
1.3 Remicade (infliximab) Drug Segment by Application
1.3.1 Global Remicade (infliximab) Drug Sales Comparison by Application: (2022-2028)
1.3.2 Crohn's Disease
1.3.3 Pediatric Crohn's Disease
1.3.4 Ulcerative Colitis
1.3.5 Pediatric Ulcerative Colitis
1.3.6 Other
1.4 Global Remicade (infliximab) Drug Market Size Estimates and Forecasts
1.4.1 Global Remicade (infliximab) Drug Revenue 2017-2028
1.4.2 Global Remicade (infliximab) Drug Sales 2017-2028
1.4.3 Remicade (infliximab) Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Remicade (infliximab) Drug Market Competition by Manufacturers
2.1 Global Remicade (infliximab) Drug Sales Market Share by Manufacturers (2017-2022)
2.2 Global Remicade (infliximab) Drug Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Remicade (infliximab) Drug Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Remicade (infliximab) Drug Manufacturing Sites, Area Served, Product Type
2.5 Remicade (infliximab) Drug Market Competitive Situation and Trends
2.5.1 Remicade (infliximab) Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Remicade (infliximab) Drug Players Market Share by Revenue
2.5.3 Global Remicade (infliximab) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Remicade (infliximab) Drug Retrospective Market Scenario by Region
3.1 Global Remicade (infliximab) Drug Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Remicade (infliximab) Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Remicade (infliximab) Drug Market Facts & Figures by Country
3.3.1 North America Remicade (infliximab) Drug Sales by Country
3.3.2 North America Remicade (infliximab) Drug Revenue by Country
3.3.3 the United States
3.3.4 Canada
3.4 Europe Remicade (infliximab) Drug Market Facts & Figures by Country
3.4.1 Europe Remicade (infliximab) Drug Sales by Country
3.4.2 Europe Remicade (infliximab) Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 UK
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Remicade (infliximab) Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Remicade (infliximab) Drug Sales by Region
3.5.2 Asia Pacific Remicade (infliximab) Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Remicade (infliximab) Drug Market Facts & Figures by Country
3.6.1 Latin America Remicade (infliximab) Drug Sales by Country
3.6.2 Latin America Remicade (infliximab) Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Remicade (infliximab) Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Remicade (infliximab) Drug Sales by Country
3.7.2 Middle East and Africa Remicade (infliximab) Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Remicade (infliximab) Drug Historic Market Analysis by Type
4.1 Global Remicade (infliximab) Drug Sales Market Share by Type (2017-2022)
4.2 Global Remicade (infliximab) Drug Revenue Market Share by Type (2017-2022)
4.3 Global Remicade (infliximab) Drug Price by Type (2017-2022)
5 Global Remicade (infliximab) Drug Historic Market Analysis by Application
5.1 Global Remicade (infliximab) Drug Sales Market Share by Application (2017-2022)
5.2 Global Remicade (infliximab) Drug Revenue Market Share by Application (2017-2022)
5.3 Global Remicade (infliximab) Drug Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Janssen
6.1.1 Janssen Corporation Information
6.1.2 Janssen Description and Business Overview
6.1.3 Janssen Remicade (infliximab) Drug Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Janssen Remicade (infliximab) Drug Product Portfolio
6.1.5 Janssen Recent Developments/Updates
6.2 Hospira
6.2.1 Hospira Corporation Information
6.2.2 Hospira Description and Business Overview
6.2.3 Hospira Remicade (infliximab) Drug Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Hospira Remicade (infliximab) Drug Product Portfolio
6.2.5 Hospira Recent Developments/Updates
6.3 Celltrion Healthcare
6.3.1 Celltrion Healthcare Corporation Information
6.3.2 Celltrion Healthcare Description and Business Overview
6.3.3 Celltrion Healthcare Remicade (infliximab) Drug Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Celltrion Healthcare Remicade (infliximab) Drug Product Portfolio
6.3.5 Celltrion Healthcare Recent Developments/Updates
6.4 Epirus Biopharmaceuticals
6.4.1 Epirus Biopharmaceuticals Corporation Information
6.4.2 Epirus Biopharmaceuticals Description and Business Overview
6.4.3 Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Epirus Biopharmaceuticals Remicade (infliximab) Drug Product Portfolio
6.4.5 Epirus Biopharmaceuticals Recent Developments/Updates
6.5 Samsung Bioepsis
6.5.1 Samsung Bioepsis Corporation Information
6.5.2 Samsung Bioepsis Description and Business Overview
6.5.3 Samsung Bioepsis Remicade (infliximab) Drug Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Samsung Bioepsis Remicade (infliximab) Drug Product Portfolio
6.5.5 Samsung Bioepsis Recent Developments/Updates
7 Remicade (infliximab) Drug Manufacturing Cost Analysis
7.1 Remicade (infliximab) Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Remicade (infliximab) Drug
7.4 Remicade (infliximab) Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Remicade (infliximab) Drug Distributors List
8.3 Remicade (infliximab) Drug Customers
9 Remicade (infliximab) Drug Market Dynamics
9.1 Remicade (infliximab) Drug Industry Trends
9.2 Remicade (infliximab) Drug Market Drivers
9.3 Remicade (infliximab) Drug Market Challenges
9.4 Remicade (infliximab) Drug Market Restraints
10 Global Market Forecast
10.1 Remicade (infliximab) Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Remicade (infliximab) Drug by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Remicade (infliximab) Drug by Type (2023-2028)
10.2 Remicade (infliximab) Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Remicade (infliximab) Drug by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Remicade (infliximab) Drug by Application (2023-2028)
10.3 Remicade (infliximab) Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Remicade (infliximab) Drug by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Remicade (infliximab) Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
